UniProt ID | CO2A1_HUMAN | |
---|---|---|
UniProt AC | P02458 | |
Protein Name | Collagen alpha-1(II) chain {ECO:0000305} | |
Gene Name | COL2A1 {ECO:0000312|HGNC:HGNC:2200} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1487 | |
Subcellular Localization | Secreted, extracellular space, extracellular matrix . | |
Protein Description | Type II collagen is specific for cartilaginous tissues. It is essential for the normal embryonic development of the skeleton, for linear growth and for the ability of cartilage to resist compressive forces.. | |
Protein Sequence | MIRLGAPQTLVLLTLLVAAVLRCQGQDVQEAGSCVQDGQRYNDKDVWKPEPCRICVCDTGTVLCDDIICEDVKDCLSPEIPFGECCPICPTDLATASGQPGPKGQKGEPGDIKDIVGPKGPPGPQGPAGEQGPRGDRGDKGEKGAPGPRGRDGEPGTPGNPGPPGPPGPPGPPGLGGNFAAQMAGGFDEKAGGAQLGVMQGPMGPMGPRGPPGPAGAPGPQGFQGNPGEPGEPGVSGPMGPRGPPGPPGKPGDDGEAGKPGKAGERGPPGPQGARGFPGTPGLPGVKGHRGYPGLDGAKGEAGAPGVKGESGSPGENGSPGPMGPRGLPGERGRTGPAGAAGARGNDGQPGPAGPPGPVGPAGGPGFPGAPGAKGEAGPTGARGPEGAQGPRGEPGTPGSPGPAGASGNPGTDGIPGAKGSAGAPGIAGAPGFPGPRGPPGPQGATGPLGPKGQTGEPGIAGFKGEQGPKGEPGPAGPQGAPGPAGEEGKRGARGEPGGVGPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERGPSGLAGPKGANGDPGRPGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQGARGQPGVMGFPGPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERGEQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDVGEKGPEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAGFAGPPGADGQPGAKGEQGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPAGPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASGDRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSGETGPAGPPGNPGPPGPPGPPGPGIDMSAFAGLGPREKGPDPLQYMRADQAAGGLRQHDAEVDATLKSLNNQIESIRSPEGSRKNPARTCRDLKLCHPEWKSGDYWIDPNQGCTLDAMKVFCNMETGETCVYPNPANVPKKNWWSSKSKEKKHIWFGETINGGFHFSYGDDNLAPNTANVQMTFLRLLSTEGSQNITYHCKNSIAYLDEAAGNLKKALLIQGSNDVEIRAEGNSRFTYTALKDGCTKHTGKWGKTVIEYRSQKTSRLPIIDIAPMDIGGPEQEFGVDIGPVCFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
41 | Phosphorylation | CVQDGQRYNDKDVWK CCCCCCCCCCCCCCC | 21.59 | - | |
74 | Ubiquitination | IICEDVKDCLSPEIP HHCCCHHHHCCCCCC | 38.14 | 27667366 | |
121 | Ubiquitination | DIVGPKGPPGPQGPA HCCCCCCCCCCCCCC | 36.48 | 27667366 | |
143 | Ubiquitination | DRGDKGEKGAPGPRG CCCCCCCCCCCCCCC | 69.87 | 27667366 | |
190 | O-linked_Glycosylation | MAGGFDEKAGGAQLG HCCCCCCCCCCCEEE | 54.93 | - | |
190 | Ubiquitination | MAGGFDEKAGGAQLG HCCCCCCCCCCCEEE | 54.93 | 27667366 | |
190 | Hydroxylation | MAGGFDEKAGGAQLG HCCCCCCCCCCCEEE | 54.93 | - | |
191 | Ubiquitination | AGGFDEKAGGAQLGV CCCCCCCCCCCEEEE | 21.43 | 27667366 | |
287 | O-linked_Glycosylation | TPGLPGVKGHRGYPG CCCCCCCCCCCCCCC | 55.72 | - | |
287 | Hydroxylation | TPGLPGVKGHRGYPG CCCCCCCCCCCCCCC | 55.72 | - | |
299 | Hydroxylation | YPGLDGAKGEAGAPG CCCCCCCCCCCCCCC | 63.91 | - | |
299 | O-linked_Glycosylation | YPGLDGAKGEAGAPG CCCCCCCCCCCCCCC | 63.91 | - | |
308 | Hydroxylation | EAGAPGVKGESGSPG CCCCCCCCCCCCCCC | 63.98 | - | |
308 | O-linked_Glycosylation | EAGAPGVKGESGSPG CCCCCCCCCCCCCCC | 63.98 | - | |
374 | Hydroxylation | FPGAPGAKGEAGPTG CCCCCCCCCCCCCCC | 64.30 | - | |
374 | O-linked_Glycosylation | FPGAPGAKGEAGPTG CCCCCCCCCCCCCCC | 64.30 | - | |
536 | Phosphorylation | APGERGPSGLAGPKG CCCCCCCCCCCCCCC | 49.62 | - | |
542 | Acetylation | PSGLAGPKGANGDPG CCCCCCCCCCCCCCC | 70.50 | 158689 | |
608 | Hydroxylation | VMGFPGPKGANGEPG CCCCCCCCCCCCCCC | 76.27 | - | |
608 | O-linked_Glycosylation | VMGFPGPKGANGEPG CCCCCCCCCCCCCCC | 76.27 | - | |
620 | O-linked_Glycosylation | EPGKAGEKGLPGAPG CCCCCCCCCCCCCCC | 65.90 | - | |
620 | Hydroxylation | EPGKAGEKGLPGAPG CCCCCCCCCCCCCCC | 65.90 | - | |
659 | Hydroxylation | ERGEQGAPGPSGFQG CCCCCCCCCCCCCCC | 63.15 | - | |
668 | Hydroxylation | PSGFQGLPGPPGPPG CCCCCCCCCCCCCCC | 61.13 | - | |
670 | Hydroxylation | GFQGLPGPPGPPGEG CCCCCCCCCCCCCCC | 28.83 | - | |
671 | Hydroxylation | FQGLPGPPGPPGEGG CCCCCCCCCCCCCCC | 74.06 | - | |
674 | Hydroxylation | LPGPPGPPGEGGKPG CCCCCCCCCCCCCCC | 60.42 | - | |
764 | Acetylation | AAGIAGPKGDRGDVG CCCCCCCCCCCCCCC | 72.95 | 164033 | |
773 | Acetylation | DRGDVGEKGPEGAPG CCCCCCCCCCCCCCC | 74.06 | 19809335 | |
907 | Hydroxylation | GAAGRVGPPGSNGNP CCCCCCCCCCCCCCC | 27.50 | - | |
908 | Hydroxylation | AAGRVGPPGSNGNPG CCCCCCCCCCCCCCC | 53.57 | - | |
914 | Hydroxylation | PPGSNGNPGPPGPPG CCCCCCCCCCCCCCC | 59.05 | - | |
920 | Hydroxylation | NPGPPGPPGPSGKDG CCCCCCCCCCCCCCC | 73.56 | - | |
1061 | Phosphorylation | VKGDRGETGAVGAPG CCCCCCCCCCCCCCC | 33.01 | 24667141 | |
1130 | Hydroxylation | EPGERGLKGHRGFTG CCCCCCCCCCCCCCC | 56.34 | - | |
1130 | O-linked_Glycosylation | EPGERGLKGHRGFTG CCCCCCCCCCCCCCC | 56.34 | - | |
1144 | Hydroxylation | GLQGLPGPPGPSGDQ CCCCCCCCCCCCCCC | 28.83 | - | |
1181 | Hydroxylation | KDGANGIPGPIGPPG CCCCCCCCCCCCCCC | 43.86 | - | |
1186 | Hydroxylation | GIPGPIGPPGPRGRS CCCCCCCCCCCCCCC | 31.24 | - | |
1187 | Hydroxylation | IPGPIGPPGPRGRSG CCCCCCCCCCCCCCC | 61.27 | - | |
1201 | Hydroxylation | GETGPAGPPGNPGPP CCCCCCCCCCCCCCC | 35.41 | - | |
1202 | Hydroxylation | ETGPAGPPGNPGPPG CCCCCCCCCCCCCCC | 55.03 | - | |
1205 | Hydroxylation | PAGPPGNPGPPGPPG CCCCCCCCCCCCCCC | 63.68 | - | |
1207 | Hydroxylation | GPPGNPGPPGPPGPP CCCCCCCCCCCCCCC | 31.75 | - | |
1208 | Hydroxylation | PPGNPGPPGPPGPPG CCCCCCCCCCCCCCC | 74.06 | - | |
1211 | Hydroxylation | NPGPPGPPGPPGPGI CCCCCCCCCCCCCCC | 74.06 | - | |
1213 | Hydroxylation | GPPGPPGPPGPGIDM CCCCCCCCCCCCCCH | 36.13 | - | |
1214 | Hydroxylation | PPGPPGPPGPGIDMS CCCCCCCCCCCCCHH | 68.47 | - | |
1307 | Phosphorylation | IDPNQGCTLDAMKVF ECCCCCCCHHHEEEH | 34.20 | - | |
1388 | N-linked_Glycosylation | LSTEGSQNITYHCKN HCCCCCCCEEEEECC | 30.21 | UniProtKB CARBOHYD | |
1416 | Phosphorylation | KALLIQGSNDVEIRA HEEEECCCCCEEEEE | 17.30 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CO2A1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CO2A1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CO2A1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BMP2_HUMAN | BMP2 | physical | 10085302 | |
ANXA5_HUMAN | ANXA5 | physical | 1397263 | |
PDGFA_HUMAN | PDGFA | physical | 8900172 | |
PDGFB_HUMAN | PDGFB | physical | 8900172 | |
HYAL1_HUMAN | HYAL1 | physical | 21988832 | |
TF65_HUMAN | RELA | physical | 21988832 | |
PLOD1_HUMAN | PLOD1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
183900 | Spondyloepiphyseal dysplasia congenital type (SEDC) | |||||
184250 | Spondyloepimetaphyseal dysplasia, Strudwick type (SEMDSTWK) | |||||
200610 | Achondrogenesis 2 (ACG2) | |||||
150600 | Legg-Calve-Perthes disease (LCPD) | |||||
156550 | Kniest dysplasia (KD) | |||||
608805 | Primary avascular necrosis of femoral head (ANFH) | |||||
604864 | Osteoarthritis with mild chondrodysplasia (OACD) | |||||
151210 | Platyspondylic lethal skeletal dysplasia Torrance type (PLSD-T) | |||||
132450 | Multiple epiphyseal dysplasia with myopia and conductive deafness (EDMMD) | |||||
271700 | Spondyloperipheral dysplasia (SPD) | |||||
108300 | Stickler syndrome 1 (STL1) | |||||
609508 | Stickler syndrome 1 non-syndromic ocular (STL1O) | |||||
609508 | Rhegmatogenous retinal detachment autosomal dominant (DRRD) | |||||
609162 | Czech dysplasia (CZECHD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...